Malaria vaccine price cut will protect 7 million more children by 2030
Malaria vaccine price cut: a landmark deal between Gavi and UNICEF has reduced the cost of the R21/Matrix-M malaria vaccine by roughly 25%, dropping the price to under per dose. The savings unlock more than 30 million additional doses, extending protection to an estimated 7 million more children across 24 African countries by 2030. The agreement integrates R21 into routine immunization programs, making it part of standard care rather than a one-off campaign. In a region where malaria kills a child every two minutes, this financing breakthrough offers a replicable model for expanding access to lifesaving vaccines worldwide.


